There was no recurrence 1 year after radical mastectomy.[13] A 68-year-old patient with advanced breast cancer and a huge skin ulcer received long-term combined treatment of trastuzumab (>400 times), aromatase inhibitors, and anti-cancer drugs. Here, CYP19A1 is linked to breast cancer.